133 related articles for article (PubMed ID: 7634391)
21. Divide and rule.
Boyle CC
Hum Exp Toxicol; 1996 Apr; 15(4):364-6. PubMed ID: 8845230
[No Abstract] [Full Text] [Related]
22. Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin.
Grasl-Kraupp B; Huber W; Timmermann-Trosiener I; Schulte-Hermann R
Carcinogenesis; 1993 Nov; 14(11):2435-7. PubMed ID: 8242878
[TBL] [Abstract][Full Text] [Related]
23. Effect of three tumour promoters on the stability of hepatocyte cultures and apoptosis after transforming growth factor-beta 1.
Oberhammer FA; Qin HM
Carcinogenesis; 1995 Jun; 16(6):1363-71. PubMed ID: 7788856
[TBL] [Abstract][Full Text] [Related]
24. Genotoxic effects of selected peroxisome proliferators.
Reisenbichler H; Eckl PM
Mutat Res; 1993 Apr; 286(2):135-44. PubMed ID: 7681524
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883.
Eacho PI; Lanier TL; Brodhecker CA
Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515
[TBL] [Abstract][Full Text] [Related]
26. A dominant negative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin.
Cosulich SC; James NH; Needham MR; Newham PP; Bundell KR; Roberts RA
Carcinogenesis; 2000 Sep; 21(9):1757-60. PubMed ID: 10964109
[TBL] [Abstract][Full Text] [Related]
27. Assessment of peroxisome proliferation and liver growth-stimulating potential by nondirectly genotoxic compounds in cultured hepatocytes.
Bieri F; Stäubli W; Kelly S; Waechter F; Bentley P
Mol Toxicol; 1987-1988 Fall; 1(4):439-44. PubMed ID: 3151502
[TBL] [Abstract][Full Text] [Related]
28. Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin.
Holden PR; Hasmall SC; James NH; West DR; Brindle RD; Gonzalez FJ; Peters JM; Roberts RA
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):29-39. PubMed ID: 10726969
[TBL] [Abstract][Full Text] [Related]
29. Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
Gerbracht U; Bursch W; Kraus P; Putz B; Reinacher M; Timmermann-Trosiener I; Schulte-Hermann R
Carcinogenesis; 1990 Apr; 11(4):617-24. PubMed ID: 1691053
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures.
Goll V; Alexandre E; Viollon-Abadie C; Nicod L; Jaeck D; Richert L
Toxicol Appl Pharmacol; 1999 Oct; 160(1):21-32. PubMed ID: 10502499
[TBL] [Abstract][Full Text] [Related]
31. Suppression of hepatocyte apoptosis and induction of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphlathate (DEHP) and the mouse hepatocarcinogen 1,4-dichlorobenzene (DCB).
James NH; Soames AR; Roberts RA
Arch Toxicol; 1998 Dec; 72(12):784-90. PubMed ID: 9950075
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
Lake BG; Evans JG; Cunninghame ME; Price RJ
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
[TBL] [Abstract][Full Text] [Related]
33. Cleavage of poly(ADP-ribose) transferase during p53-independent apoptosis in rat liver after treatment with N-nitrosomorpholine and cyproterone acetate.
Weşierska-Gadek J; Bugajska-Schretter A; Löw-Baselli A; Grasl-Kraupp B
Mol Carcinog; 1999 Apr; 24(4):263-75. PubMed ID: 10326863
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of peroxisomal enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin.
Grasl-Kraupp B; Huber W; Just W; Gibson G; Schulte-Hermann R
Carcinogenesis; 1993 May; 14(5):1007-12. PubMed ID: 8099311
[TBL] [Abstract][Full Text] [Related]
35. Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver.
Kraupp-Grasl B; Huber W; Putz B; Gerbracht U; Schulte-Hermann R
Cancer Res; 1990 Jun; 50(12):3701-8. PubMed ID: 1971196
[TBL] [Abstract][Full Text] [Related]
36. Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes.
Werner S; Kunz S; Beckurts T; Heidecke CD; Wolff T; Schwarz LR
Mutat Res; 1997 Dec; 395(2-3):179-87. PubMed ID: 9465929
[TBL] [Abstract][Full Text] [Related]
37. The use of primary cultures of adult rat hepatocytes to study induction of enzymes and DNA synthesis: effect of nafenopin and electroporation.
Muakkassah-Kelly SF; Bieri F; Waechter F; Bentley P; Stäubli W
Experientia; 1988 Oct; 44(10):823-7. PubMed ID: 3053229
[TBL] [Abstract][Full Text] [Related]
38. Role of MAP kinase signalling pathways in the mode of action of peroxisome proliferators.
Cosulich S; James N; Roberts R
Carcinogenesis; 2000 Apr; 21(4):579-84. PubMed ID: 10753189
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of nafenopin on hepatic peroxisome proliferation and replicative DNA synthesis in the rat and Syrian hamster.
Price RJ; Evans JG; Lake BG
Food Chem Toxicol; 1992 Nov; 30(11):937-44. PubMed ID: 1473786
[TBL] [Abstract][Full Text] [Related]
40. Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-kappaB and AP-1 or with expression of tumor necrosis factor alpha.
Menegazzi M; Carcereri-De Prati A; Suzuki H; Shinozuka H; Pibiri M; Piga R; Columbano A; Ledda-Columbano GM
Hepatology; 1997 Mar; 25(3):585-92. PubMed ID: 9049203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]